HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Jin Selected Research

Arsenic Trioxide (Trisenox)

1/2021Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).
1/2019The simpler, the better: oral arsenic for acute promyelocytic leukemia.
6/2018Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy.
1/2016All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis.
11/2015Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
9/2015Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy.
6/2015Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide.
5/2015[The clinical efficacy of all-trans retinoic acid plus arsenic trioxide in 177 newly diagnosed acute promyelocytic leukemia patients].
6/2014Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy.
1/2014Downregulation of hTERT: an important As2O3 induced mechanism of apoptosis in myelodysplastic syndrome.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Jin Research Topics

Disease

101Neoplasms (Cancer)
07/2022 - 01/2004
60Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2022 - 01/2004
44Leukemia
07/2021 - 02/2003
32Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 08/2004
23BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2022 - 02/2004
22Acute Promyelocytic Leukemia
07/2021 - 03/2007
21Multiple Myeloma
01/2022 - 06/2004
20Prostatic Neoplasms (Prostate Cancer)
01/2021 - 08/2010
20Renal Cell Carcinoma (Grawitz Tumor)
12/2020 - 03/2009
19Infections
08/2022 - 04/2003
17Disease Progression
10/2021 - 01/2006
15Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 11/2006
15Carcinoma (Carcinomatosis)
01/2021 - 01/2007
12Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 10/2008
12Neutropenia
01/2022 - 09/2003
12Inflammation (Inflammations)
03/2021 - 03/2011
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 01/2004
10Hemorrhage
04/2022 - 01/2014
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 01/2004
10Hypertension (High Blood Pressure)
01/2022 - 11/2007
9Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
06/2022 - 11/2007
9Lymphoma (Lymphomas)
12/2021 - 11/2005
9Neoplasm Metastasis (Metastasis)
07/2021 - 01/2007
9Carcinogenesis
01/2020 - 07/2007
8Mycoses (Diseases, Fungus)
08/2021 - 01/2016
7Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 01/2015
7Pain (Aches)
03/2021 - 03/2011
6Osteoarthritis
07/2022 - 12/2020
6Thrombocytopenia (Thrombopenia)
01/2022 - 08/2013
6Stomach Neoplasms (Stomach Cancer)
12/2021 - 11/2007
6Invasive Fungal Infections
07/2021 - 07/2008
6Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2021 - 01/2004
6Anemia
01/2021 - 03/2004
6Erectile Dysfunction
04/2014 - 09/2004
6Chromosome Aberrations (Chromosome Abnormalities)
12/2013 - 12/2004
5Philadelphia Chromosome
01/2022 - 10/2016
5Diarrhea
01/2021 - 11/2012
5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021 - 06/2008
5Hepatitis B
05/2020 - 02/2009
4Fever (Fevers)
08/2022 - 01/2008
4Pneumonia (Pneumonitis)
07/2021 - 11/2012

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
07/2021 - 03/2006
20Arsenic Trioxide (Trisenox)FDA Link
01/2021 - 06/2004
19Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 08/2006
19Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 01/2008
16Pharmaceutical PreparationsIBA
01/2022 - 04/2003
15MicroRNAs (MicroRNA)IBA
08/2022 - 12/2007
15HomoharringtonineIBA
01/2022 - 07/2007
15Rituximab (Mabthera)FDA Link
06/2021 - 04/2014
14Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2010
13Bortezomib (Velcade)FDA Link
12/2021 - 11/2006
13Messenger RNA (mRNA)IBA
12/2020 - 02/2003
12Dexamethasone (Maxidex)FDA LinkGeneric
03/2021 - 10/2008
12Biological ProductsIBA
01/2021 - 01/2005
12Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021 - 12/2011
11Tyrosine Kinase InhibitorsIBA
02/2022 - 05/2008
10Prednisone (Sone)FDA LinkGeneric
01/2022 - 03/2015
10Therapeutic UsesIBA
03/2021 - 01/2006
9venetoclaxIBA
08/2022 - 01/2020
9DecitabineFDA Link
08/2022 - 06/2014
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2004
8CytokinesIBA
01/2022 - 01/2004
8Antiviral Agents (Antivirals)IBA
11/2020 - 05/2007
8Sunitinib (Sutent)FDA Link
03/2020 - 03/2010
8AclarubicinIBA
01/2020 - 01/2008
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021 - 03/2015
7Lenalidomide (CC 5013)FDA Link
01/2021 - 06/2013
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 03/2015
7CaspasesIBA
09/2014 - 08/2007
7triptolideIBA
06/2012 - 02/2004
6Azacitidine (5 Azacytidine)FDA Link
10/2022 - 06/2018
6Inosine Triphosphate (ITP)IBA
01/2022 - 01/2015
6Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 10/2019
6ArsenicIBA
07/2021 - 11/2013
6Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 03/2015
6EnzymesIBA
01/2021 - 06/2004
6Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2021 - 06/2014
6RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2014 - 01/2006
5Hemoglobins (Hemoglobin)IBA
08/2022 - 10/2013
5abivertinibIBA
06/2022 - 04/2018
5zanubrutinibIBA
01/2022 - 01/2020
5Dasatinib (BMS 354825)FDA Link
01/2022 - 11/2012
5ibrutinibIBA
02/2021 - 02/2017
5Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021 - 11/2007
5Docetaxel (Taxotere)FDA Link
01/2021 - 08/2015
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 09/2008
5LigandsIBA
04/2020 - 05/2017
5AntigensIBA
09/2013 - 09/2003
4Anti-Bacterial Agents (Antibiotics)IBA
07/2021 - 06/2005

Therapy/Procedure

90Therapeutics
10/2022 - 11/2004
40Drug Therapy (Chemotherapy)
07/2021 - 12/2004
10Hematopoietic Stem Cell Transplantation
08/2021 - 12/2016
9Prostatectomy (Retropubic Prostatectomy)
01/2019 - 02/2012
8Stents
04/2022 - 03/2011
8Nephrectomy
12/2020 - 07/2012
8Induction Chemotherapy
06/2019 - 01/2008
7Salvage Therapy
07/2021 - 08/2013
7Aftercare (After-Treatment)
08/2020 - 03/2006
5Transplantation
08/2021 - 11/2018
5Castration
01/2021 - 08/2015